Kidney Cancer and a Second Opinion: Debbie's Immunotherapy Story
After a devastating kidney cancer diagnosis, Debbie sought a second opinion and enrolled in an immunotherapy clinical trial.
In January 2015, Debbie was diagnosed with stage IV kidney cancer and told she had 18 months to live. Debbie and her husband went to Roswell Park Comprehensive Cancer Center, near their home in Buffalo, New York, for a second opinion. After surgery, her oncologist, Dr. Saby George, advised Debbie to enroll in a clinical trial combining ipilimumab (Yervoy®) and nivolumab (Opdivo®). As of April 2019, Debbie is cancer-free and enjoying retirement with her husband. https://www.cancerresearch.org/patients
This video is part of the 7th Annual Cancer Immunotherapy Month™ in June 2019, hosted by the Cancer Research Institute. Help us raise awareness of the lifesaving potential of immunotherapy for all types of cancer. Let's fuel the next scientific discoveries and breakthrough treatments through learning, engagement, and storytelling. https://www.cancerresearch.org..../join-the-cause/canc #Immune2Cancer
Immunotherapy patient stories are part of the Cancer Research Institute's Answer to Cancer Patient Education Program. Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org
SyncID: MB01AFZL6COXT5H
-
Category
No comments found